ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.

Biotechnology

Health Care

Therapeutics

ImCheck Therapeutics

Pierre d'Epenoux

Sophie Agaugué

Katrien Lemmens

Tracey Butler

Patrick BRUNE

Nabila Z.

Hans Henrik Chrois Christensen

Florence ALCARAZ

Emmanuel VALENTIN

Diane Delpy-Sampson

Claude Knopf

Carla Cano

Alem Truneh

The Leadership Team at ImCheck Therapeutics is responsible for defining the strategic vision and direction of the company, overseeing the development of innovative immuno-modulatory therapies for cancer and immune-related diseases. This team collaborates across various disciplines to drive research initiatives, manage financial resources, and ensure the successful progression of clinical programs, all while fostering partnerships that enhance the company's impact in the biopharmaceutical landscape.

Leadership Team

Research and Development Team

Finance and Administration Team

Leadership Team

About

Team members

Other teams at ImCheck Therapeutics

Research and Development Team

Finance and Administration Team